Test/Group | Sensitivity (95% CI) | Specificity (95% CI) | Positive LR (95% CI) | Negative LR (95% CI) | DOR (95% CI) |
---|---|---|---|---|---|
1. QFT-GIT | Â | Â | Â | Â | Â |
 1.1 Overall | 0.77 (0.71–0.82) | 0.70 (0.58–0.80) | 2.61 (1.80–3.80) | 0.33 (0.25–0.42) | 8.03 (4.51–14.31) |
 1.2 Risk of bias |  |  |  |  |  |
 Low risk of bias | 0.77 (0.69–0.83) | 0.69 (0.56–0.79) | 2.46 (1.83–3.31) | 0.34 (0.28–0.41) | 7.28 (5.39–9.85) |
 At risk of bias | 0.76 (0.68–0.82) | 0.71 (0.50–0.86) | 2.64 (1.36–5.12) | 0.34 (0.22–0.51) | 7.85 (2.81–21.90) |
 1.3 TB burden |  |  |  |  |  |
 High TB burden country | 0.74 (0.66–0.81) | 0.57 (0.42–0.71) | 1.74 (1.30–2.33) | 0.45 (0.36–56) | 3.84 (2.45–6.02) |
 Low TB burden country | 0.80 (0.71–0.85) | 0.77 (0.62–0.87) | 3.39 (2.02–5.68) | 0.27 (0.19–0.39) | 12.38 (5.92–25.89) |
 1.4 Excluding studies of patients with HIV and immunocompromised status | 0.79 (0.73–0.84) | 0.72 (0.59–0.83) | 2.86 (1.86–4.40) | 0.29 (0.22–0.38) | 8.85 (5.36–18.11) |
2.T-SPOT.TB | 0.74 (0.71–0.78) | 0.71 (0.49–0.86) | 2.53 (1.26–5.07) | 0.36 (0.24–0.55) | 6.96 (2.31–20.98) |